Because the relative proportions of top clones are not maintained in TILs compared with PBMCs, this may suggest that the increase in CD8+ T cells in the tumour following combination treatment occurs through a selective trafficking mechanism or there is retention of antigen-specific T cells in the tumour. Here, CD8A is linked to neoplasm.